Dow Jones

39,869.38

-0.10%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

ENDP

Endo (ENDP)

Endo International PLC

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ENDP

1 2 3 4 5 6 7 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
21/09/2023	06:45	PR Newswire (Canada)	Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting	NASDAQ:ENDP	Endo International PLC
08/08/2023	06:45	PR Newswire (US)	ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS	NASDAQ:ENDP	Endo International PLC
18/07/2023	15:30	PR Newswire (US)	Endo Launches Bivalirudin Injection in Ready-to-Use Vials	NASDAQ:ENDP	Endo International PLC
13/07/2023	15:30	PR Newswire (US)	Endo Presents New Data at the American Podiatric Medical Association Annual Meeting	NASDAQ:ENDP	Endo International PLC
29/06/2023	15:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ENDP	Endo International PLC
12/06/2023	06:30	PR Newswire (US)	Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe	NASDAQ:ENDP	Endo International PLC
08/05/2023	06:30	PR Newswire (US)	ENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS	NASDAQ:ENDP	Endo International PLC
17/04/2023	06:45	PR Newswire (US)	Endo Announces Launch of Argatroban Injection Through Premier's ProRx® Private-Label Program	NASDAQ:ENDP	Endo International PLC
03/04/2023	15:30	PR Newswire (Canada)	Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension	NASDAQ:ENDP	Endo International PLC
13/03/2023	15:17	PR Newswire (US)	Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants With Plantar Fibromatosis	NASDAQ:ENDP	Endo International PLC
10/03/2023	06:30	PR Newswire (US)	Endo Launches First Generic Version of Pylera® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) Capsules	NASDAQ:ENDP	Endo International PLC
06/03/2023	15:14	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ENDP	Endo International PLC
27/02/2023	16:15	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ENDP	Endo International PLC
27/02/2023	16:00	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:ENDP	Endo International PLC
13/02/2023	11:39	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ENDP	Endo International PLC
06/02/2023	06:30	PR Newswire (US)	Endo Launches "Man With a Plan" Campaign to Support Men With Symptoms of Peyronie's Disease	NASDAQ:ENDP	Endo International PLC
31/01/2023	16:06	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:ENDP	Endo International PLC
06/12/2022	15:45	PR Newswire (US)	Endo to Cease Production and Sale of Qwo® (collagenase clostridium histolyticum-aaes)	NASDAQ:ENDP	Endo International PLC
09/11/2022	10:37	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ENDP	Endo International PLC
27/10/2022	06:30	PR Newswire (US)	Endo and SMSNA Launch App to Provide Peyronie's Disease Self-Assessment Tool	NASDAQ:ENDP	Endo International PLC
07/10/2022	06:30	PR Newswire (US)	Endo Presents New Qwo® (collagenase clostridium histolyticum-aaes) Data at the American Society for Dermatologic Surgery's Annual Meeting	NASDAQ:ENDP	Endo International PLC
05/10/2022	06:30	PR Newswire (US)	Endo Launches Unscripted Video Series With Real Dupuytren's Contracture Patients	NASDAQ:ENDP	Endo International PLC
08/09/2022	12:44	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ENDP	Endo International PLC
17/08/2022	05:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ENDP	Endo International PLC
16/08/2022	21:00	PR Newswire (US)	Endo Enters Into Restructuring Support Agreement with Senior Secured Debtholders to Strengthen Financial Position and Advance Ongoing Business Transformation	NASDAQ:ENDP	Endo International PLC
10/08/2022	13:08	Dow Jones News	Endo Bondholder Group Continues to Call on Company Not to File for Bankruptcy	NASDAQ:ENDP	Endo International PLC
09/08/2022	08:00	PR Newswire (US)	New Drug Filing for Cenobamate Accepted for Review in Canada and Israel	NASDAQ:ENDP	Endo International PLC
09/08/2022	07:45	PR Newswire (US)	ENDO REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS	NASDAQ:ENDP	Endo International PLC
08/08/2022	15:30	PR Newswire (Canada)	Laboratoires Paladin inc. annonce que Santé Canada a accepté la demande d'autorisation de mise sur le marché des comprimés de cénobamate comme traitement d'appoint pour la prise en charge des crises partielles chez les adultes atteints d'épilepsie	NASDAQ:ENDP	Endo International PLC
08/08/2022	15:30	PR Newswire (Canada)	Paladin Labs Announces Health Canada's Filing Acceptance of Cenobamate Tablets as an Adjunctive Therapy for the Management of Partial-Onset Seizures in Adults with Epilepsy	NASDAQ:ENDP	Endo International PLC